StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) bonds

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$4.85−0.02 (-0.41%)

Close on Nov 16, 2026Market cap $304.79MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$17.24M
$14.15M due within a year
Net debt
$12.83M
After $4.41M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2023

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Cytosorbents's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Loan and Security Agreement
Convertible at $1 a share
Floating + 5.00%–$17.50M
Tranche 1-Loan and Security Agreement–$10.00M–
Tranche 2a-Loan and Security Agreement–$2.50M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
First Tranche$5.00M
Second Tranche$5.00M
Third Tranche$5.00M

See a number that looks wrong?